Short answer
ORASURE TECHNOLOGIES INC (OSUR) filed an 8-K current report with the SEC on June 11, 2026 reporting Item 8.01 (Other Events). FDA clearance expands Colli-Pee™ Dx use with Roche STI tests for four infections.
ORASURE TECHNOLOGIES INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- FDA clearance expands Colli-Pee™ Dx use with Roche STI tests for four infections
- Compatibility covers Roche cobas 5800, 6800, and 8800 molecular diagnostic systems
- At-home first-void urine collection supports both male and female patient testing
- Potential commercial relevance through expanded access to decentralized STI screening
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ORASURE TECHNOLOGIES INC 8-K filings
Get the next OSUR 8-K as it lands
Follow OSUR for push alerts, or ask the research agent what this filing means.